Trial · NCT07892430
Psychological, Hormonal, and Physical Performance Profiles in Adolescent Male Football Players
NCT07892430, Completed, Firat University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Psychological, Hormonal, and Physical Performance Profiles in Adolescent Male Football Players. Trials, record NCT07892430. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892430
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Psychological, Hormonal, and Physical Performance Profiles in Adolescent Male Football Players
- NCT number
- NCT07892430
- Status
- Completed
- Enrollment
- 21 participants, actual
- Lead sponsor
- Firat University
- Conditions
- Adolescence, Body Composition, Physical Performance, Mental Toughness
- First posted
- 2026-10-23
- Last updated
- 2026-11-12
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hormonal Markers | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the first to the final session. | Serum total testosterone, free triiodothyronine (FT3), and free thyroxine (FT4) concentrations measured in ng/mL or pg/mL via immunoassay in a 5 mL venous blood sample. |
| Primary | Psychological Well-Being and Mental Toughness Scores | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the final session. | Psychological well-being assessed using a 23-item scale (23-115 points) and mental toughness assessed using an eight-item index (mean score: 1-7), where higher scores indicate better well-being or toughness. |
| Primary | Jumping Performance | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the final session. | Countermovement jump height and standing long jump distance measured in centimeters (cm). The best of two trials was retained, where higher values indicate better performance. |
| Primary | Body Weight | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the final session. | Body weight measured in kilograms (kg) using bioelectrical impedance. |
| Primary | Kick Speed | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the final session. | Kick speed measured in kilometers per hour (km/h). The best of two trials was retained, where higher values indicate better performance. |
| Primary | Sprint and Agility Times | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the final session. | 10 and 20 m sprint and T-test times measured in seconds (s). The best of two trials was retained, where shorter times indicate better performance. |
| Primary | Height | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the final session. | Height measured in meters (m) using a stadiometer. |
| Primary | Body Mass Index (BMI) | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the final session. | Body Mass Index (BMI) calculated as weight in kilograms divided by height in meters squared (kg/m\^2). |
| Primary | Body Composition Percentages | Assessed once per participant across four assessment sessions spaced 48 hours apart, over approximately 6 days from the final session. | Body fat percentage and skeletal muscle percentage measured as a percentage (%) using bioelectrical impedance. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07892430
GET https://conductscience.org/api/trials/v1/NCT07892430/registered